Delivery Order SPE2DB22D2206-SPE2DB25FHE35
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565616879 - GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $15,536.46. The contract is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4565978297 GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML. The contract has a ceiling value of $1,398.76 and an ultimate completion date of October 1, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Glycopyrrolate 0.2 mg/ml vial, 5 ml, a medication used for various medical purposes. The contract has a ceiling value of $1,266.99 and is a firm fixed-price contract with a period of performance through May 8, 2025. The contract is not set aside for any specific business category....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a critical medical product, with a ceiling value of $1,338.90 and a performance period through September 25, 2023. This Delivery Order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,147.21, is for the delivery of glycopyrrolate 0.2 mg/ml vials to support military and federal healthcare programs. The contract has a completion date of February 21, 2024 and is a firm fixed-price delivery order. No set-aside designation was used....
This federal contract award, valued at $2,090.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567362924 ! GLYCOPYRROLATE 1 MG/5 ML VIAL 5ML, a pharmaceutical product. This contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,050.14, is for the delivery of 4 mg/20 ml vials of the medication glycopyrrolate. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
The U.S. federal government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of pharmaceuticals, specifically the drug glycopyrrolate 1 mg/5 ml vial 5 ml, with a ceiling value of $1,524.65. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value...